Arterial indications for the low molecular weight heparins
<p>Abstract</p> <p>Antithrombotic treatment is of proven importance in patients with acute coronary syndromes. There is now accumulating evidence from several clinical trials in patients with unstable angina pectoris that the low molecular weight heparins (LMWHs) are at least as ef...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2001-09-01
|
Series: | Current Controlled Trials in Cardiovascular Medicine |
Subjects: | |
Online Access: | http://cvm.controlled-trials.com/content/2/5/233 |